Specific modulation of calmodulin activity induces a dramatic production of superoxide by alveolar macrophages

Robert Ten Broeke1, Thea Leusink-Muis, Rogier Hilberdink

  • 1Department of Pharmacology and Pathophysiology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.

Insights

Calcium-like peptide 2 (CALP2) activates alveolar macrophages to produce reactive oxygen species via the calcium/calmodulin pathway, offering potential new therapies for airway inflammation and oxidative stress.

Area of Science:

  • Pulmonary immunology
  • Cellular signaling
  • Oxidative stress research

Background:

  • Airway inflammation in diseases like asthma and COPD involves oxidative stress from inflammatory cells.
  • Reactive oxygen species (ROS) production by macrophages, eosinophils, and neutrophils contributes to airway disease pathogenesis.
  • Calmodulin (CaM), a calcium-sensing protein, regulates cellular functions including calcium channels.

Purpose of the Study:

  • To investigate if CaM modulates intracellular calcium ([Ca(2+)](i)) and ROS production in pulmonary inflammatory cells.
  • To determine the role of calcium channels in CaM-mediated ROS production.
  • To assess the effect of calcium-like peptide 2 (CALP2) on ROS generation in specific pulmonary cell types.

Main Methods:

  • Purified broncho-alveolar lavage cells from guinea-pigs were used.
  • Radical production was measured in response to CALP2 stimulation.
  • Inhibitors of NADPH oxidase (DPI), superoxide (SOD), CaM (W7), and calcium channels (lanthanum) were employed.

Main Results:

  • CALP2 strongly activated ROS production in alveolar macrophages.
  • CALP2 showed mild activation of neutrophils and no activation of eosinophils.
  • CALP2-induced ROS production was intracellular, blocked by DPI, SOD, and W7, and partly inhibited by lanthanum.

Conclusions:

  • Alveolar macrophages, but not neutrophils or eosinophils, produce significant ROS via the calcium/CaM pathway when stimulated by CALP2.
  • These findings suggest the calcium/CaM pathway as a therapeutic target for managing oxidative stress in airway diseases.